Edwards Lifesciences Corp. (EW)
83.46
-0.89
(-1.06%)
USD |
NYSE |
Jan 20, 16:00
83.29
-0.17
(-0.20%)
After-Hours: 20:00
Edwards Lifesciences EPS Diluted (Quarterly): 0.5004 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Abbott Laboratories | 0.9146 |
| Artivion, Inc. | 0.1332 |
| Zimmer Biomet Holdings, Inc. | 1.162 |
| Stryker Corp. | 2.221 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 292.30M |
| Revenue (Quarterly) | 1.553B |
| Total Expenses (Quarterly) | 1.26B |
| Enterprise Value | 45.29B |
| Gross Profit Margin (Quarterly) | 78.29% |
| Profit Margin (Quarterly) | 18.82% |
| Earnings Yield | 2.81% |
| Operating Earnings Yield | 3.26% |
| Normalized Earnings Yield | 3.163 |